OncoInv
Houten, Netherlands
Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnostics is vital. As more and curative treatments options are available the earlier cancer is diagnosed and the negative impact on quality of life is reduced. We are in need of a multi cancer test and OncoInv offers you one. OncoSeek® is a low cost detection and diagnostics test for cancer. OncoSeek® uses a combination of 7 specific plasma tumor markers, a new multivariate algorithm, big data and AI. It performs early screening for the most common cancers, calculates the cancer risk score (CRS), and traces the cancer tissue of origin (TOO). It’s scientifically validated and CE-certified. OncoSeek can be easily implemented as it uses existing medical infrastructure.
Company Info
- Founded
- 2023
- Website
- oncoinv.org/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of OncoInv?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.